INTELLIA THERAPEUTICS, INC. Public Float
INTELLIA THERAPEUTICS, INC. (NTLA) had Public Float of $869.49 million as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $869.49M.
- 2024-06-30: Entity Public Float $1.92B.
- 2023-06-30: Entity Public Float $3.57B.
- 2022-06-30: Entity Public Float $3.89B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $869.49M 10-K · filed 2026-02-26 |
| 2024-06-30 | $1.92B 10-K · filed 2025-02-27 |
| 2023-06-30 | $3.57B 10-K · filed 2024-02-22 |
| 2022-06-30 | $3.89B 10-K · filed 2023-02-23 |
| 2021-06-30 | $10.93B 10-K · filed 2022-02-24 |
| 2020-06-30 | $1.18B 10-K · filed 2021-02-26 |
| 2019-06-28 | $741.05M 10-K · filed 2020-02-27 |
| 2018-06-29 | $1.11B 10-K · filed 2019-02-27 |
| 2017-06-30 | $235.30M 10-K · filed 2018-03-14 |
| 2016-06-30 | $453.20M 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |